1. Home
  2. PRFX vs SHPH Comparison

PRFX vs SHPH Comparison

Compare PRFX & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRFX
  • SHPH
  • Stock Information
  • Founded
  • PRFX 2007
  • SHPH 2012
  • Country
  • PRFX Israel
  • SHPH United States
  • Employees
  • PRFX N/A
  • SHPH N/A
  • Industry
  • PRFX Biotechnology: Pharmaceutical Preparations
  • SHPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRFX Health Care
  • SHPH Health Care
  • Exchange
  • PRFX Nasdaq
  • SHPH Nasdaq
  • Market Cap
  • PRFX 2.8M
  • SHPH 2.3M
  • IPO Year
  • PRFX 2020
  • SHPH 2022
  • Fundamental
  • Price
  • PRFX $1.33
  • SHPH $3.42
  • Analyst Decision
  • PRFX Hold
  • SHPH
  • Analyst Count
  • PRFX 1
  • SHPH 0
  • Target Price
  • PRFX N/A
  • SHPH N/A
  • AVG Volume (30 Days)
  • PRFX 138.2K
  • SHPH 157.2K
  • Earning Date
  • PRFX 08-15-2025
  • SHPH 09-03-2025
  • Dividend Yield
  • PRFX N/A
  • SHPH N/A
  • EPS Growth
  • PRFX N/A
  • SHPH N/A
  • EPS
  • PRFX N/A
  • SHPH N/A
  • Revenue
  • PRFX N/A
  • SHPH N/A
  • Revenue This Year
  • PRFX N/A
  • SHPH N/A
  • Revenue Next Year
  • PRFX N/A
  • SHPH N/A
  • P/E Ratio
  • PRFX N/A
  • SHPH N/A
  • Revenue Growth
  • PRFX N/A
  • SHPH N/A
  • 52 Week Low
  • PRFX $1.25
  • SHPH $3.00
  • 52 Week High
  • PRFX $16.63
  • SHPH $82.50
  • Technical
  • Relative Strength Index (RSI)
  • PRFX 35.46
  • SHPH 39.42
  • Support Level
  • PRFX $1.25
  • SHPH $3.33
  • Resistance Level
  • PRFX $1.55
  • SHPH $3.83
  • Average True Range (ATR)
  • PRFX 0.07
  • SHPH 0.23
  • MACD
  • PRFX -0.00
  • SHPH -0.02
  • Stochastic Oscillator
  • PRFX 26.67
  • SHPH 10.78

About PRFX PainReform Ltd.

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

Share on Social Networks: